“Development of Stimuli-Responsive Nanoparticles for Targeted Delivery of Encorafenib in BRAF-Mutant Cancer Therapy”, IJRDT, vol. 4, no. 1, pp. 85–109, Mar. 2026, doi: 10.62218/ijrdt.v4i1.170.